Under a new agreement, Biodesix and Inivata will investigate the clinical utility of blood-based next-generation sequencing tests for patients with non-small cell lung cancer.
Read MoreThe Association for Molecular Pathology has released a micro-costing analysis tool to aid in calculating the cost of next-generation sequencing (NGS) assays.
Read More
Featured cancer diagnostics products include the Therascreen EGFR RGQ Plasma PCR kit from Qiagen, a KRAS screening multiplex kit from Bio-Rad Laboratories, and the Prostate Health Index from Beckman Coulter Diagnostics.
Read More
Advances in whole-genome sequencing technology such as copy-number assays are driving significant progress in the diagnosis and treatment of cancer.
Read More
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
Read More